Heart Failure Treatment and Management
Heart Failure Treatment and Management is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 50k research works in it since 1950. 19.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and management of heart failure, including guidelines, epidemiology, B-type natriuretic peptide testing, cardiovascular disease burden, hospital readmission rates, risk prediction models, and the impact of renal function on outcomes.
- Heart Failure
- Guidelines
- Diagnosis
- Treatment
- B-Type Natriuretic Peptide
- Epidemiology
- Cardiovascular Disease
- Hospital Readmission
- Risk Prediction
- Renal Function
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 9.8k per year above
- Top-10% rate
- 19.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +30% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Heart Failure Treatment and Management research?
By volume, the United States and China publish the most (2.8k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.8k works
- 2 China 1k works
- 3 Japan 532 works
- 4 United Kingdom 487 works
- 5 Italy 444 works
- 6 Spain 426 works
- 7 Germany 402 works
- 8 Australia 299 works
- 9 Canada 282 works
- 10 India 244 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Heart Failure Treatment and Management research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Heart Failure Treatment and Management research, followed by Brigham and Women's Hospital and Harvard University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 47 works
- 2 Brigham and Women's HospitalUnited States 45 works
- 3 Harvard UniversityUnited States 42 works
- 4 Cleveland ClinicUnited States 39 works
- 5 Duke UniversityUnited States 37 works
- 6 University of North Carolina at Chapel HillUnited States 32 works
- 7 University of GlasgowUnited Kingdom 31 works
- 8 Yale UniversityUnited States 30 works
- 9 Mayo Clinic in ArizonaUnited States 28 works
- 10 Johns Hopkins UniversityUnited States 28 works
Who are the leading researchers in Heart Failure Treatment and Management?
The most-cited researchers publishing on Heart Failure Treatment and Management include Gordon Guyatt, William B. Kannel and Maciej Banach.
- 1 Gordon Guyatt Canada 6.8k citations
- 2 William B. Kannel United States 5.7k citations
- 3 Maciej Banach Poland 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Heart Failure Treatment and Management research done?
The largest centres of Heart Failure Treatment and Management research in 2022–2025 are Beijing (China), Boston (United States), Tokyo (Japan) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Plymouth and Kansas City.
Largest cities, 2022–2025
Where it is the local speciality
- PlymouthUS · 23.8 works67×
- Kansas CityUS · 28.4 works9.6×
Location quotient: how much more of its research is in Heart Failure Treatment and Management than the world average.
Where is the best place to study Heart Failure Treatment and Management?
Among universities, judged by research, Karolinska Institutet, Wroclaw Medical University and University of Glasgow score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska InstitutetSweden | 70.8 | 31.3% | 6.2× | 27 | +237.2% |
| 2 | Wroclaw Medical UniversityPoland | 67.9 | 35.1% | 12.3× | 18 | +159.4% |
| 3 | University of GlasgowUnited Kingdom | 62.0 | 38.5% | 5.2× | 31 | +78.0% |
| 4 | Université de LorraineFrance | 59.4 | 53.6% | 3.5× | 9 | +227.0% |
| 5 | University of BresciaItaly | 59.3 | 36.4% | 8.8× | 14 | +43.9% |
| 6 | Duke-NUS Medical SchoolSingapore | 56.7 | 31.7% | 11.1× | 8 | — |
| 7 | Harvard UniversityUnited States | 55.6 | 34.0% | 3.3× | 42 | +32.1% |
| 8 | National University of SingaporeSingapore | 53.8 | 39.9% | 1.3× | 12 | +212.6% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 53.1 | 24.5% | 4.9× | 47 | +64.6% |
| 10 | Duke UniversityUnited States | 50.5 | 26.7% | 5.3× | 37 | +9.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Heart Failure Treatment and Management research growing?
Output in 2018–2022 was 30% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Heart Failure Treatment and Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.